Desk note · industry · Pharmaceuticals / manufacturing
US inspectors left Granules India with eleven observations at a Hyderabad plant
Granules India Ltd said on 31 October 2026 that US Food and Drug Administration inspectors finished a good manufacturing practice review at its Gagillapur, Hyderabad finished-dose site with a Form 483 listing eleven observations, the first US audit there since a February 2025 warning letter tied to an earlier inspection.

- •Granules India disclosed on 31 October 2026 that a US FDA inspection of its Gagillapur Hyderabad facility from 19 to 30 October ended with Form 483 and eleven observations.
- •The company said none of the observations related to data integrity or cross-contamination and that manufacturing and distribution continue.
- •Management pledged a comprehensive agency response within fifteen days; results for the September quarter are due on 2 November 2026.
What's going on here?
On 31 October 2026, Granules India Ltd filed with exchanges that United States Food and Drug Administration investigators completed a current good manufacturing practice inspection at its finished dosage plant in Gagillapur, Hyderabad, running from 19 to 30 October 2026. The visit ended with Form 483 carrying eleven observations. The company said this was the first US audit of the site since a warning letter dated 26 February 2025 that followed an inspection in August and September 2024. Granules stated that none of the observations involved data integrity or cross-contamination, and described them as tied to investigations, change control, equipment qualification, visual inspection controls, and documentation practices. It said production and shipments from the site continue and that it will submit a comprehensive response within fifteen days. The disclosure landed ahead of quarterly results scheduled for 2 November 2026.
What does this mean?
Form 483 is the agency’s way of flagging conditions that could lead to adulterated product if left unfixed; it is not by itself an import ban, but it raises remediation work and follow-up inspections. For a manufacturer exporting to the US, observation counts and tone matter to wholesale buyers long before share prices react. Granules’ emphasis on non-data-integrity issues suggests the fixes are procedural rather than fraud-related, yet eleven points still mean capital and trainer hours on the shop floor. The prior warning letter means regulators already had this site on a shorter leash, so response quality and closure speed will be watched closely. Generic drug buyers often dual-source capsules and tablets; one plant’s slip can shift orders to peers with cleaner inspection letters.
Why should I care?
If you invest in Indian pharma exporters, read the full 483 when published and compare management’s corrective timeline with the February 2025 warning letter closure plan. Hospitals and wholesalers sourcing from Granules should confirm alternate approvals for critical SKUs while responses are pending. Employees at the Hyderabad site should expect audit-heavy weeks even if lines keep running. Watch the 2 November earnings call for remediation cost guidance, any customer audit visits, and whether the US agency schedules a reinspection before granting new product approvals from the plant.
More desk notes
Markets / GIFT IFSC
GIFT Nifty open interest set a fresh record above $22 billion
NSE International Exchange said on 19 November 2026 that GIFT Nifty open interest reached $22.21 billion on 18 November, topping the prior October peak as offshore index contracts keep drawing hedging and speculative flow at GIFT City.
Financial services / broking
Fairfax now owns more than half of IIFL Capital Services
FIH Mauritius Investments bought an 11.8% block from promoters on 19 November 2026 for about ₹1,540 crore, lifting the Fairfax group's combined holding in IIFL Capital Services Ltd past 50% as it funds the IDBI Bank takeover.
Power transmission
Adani Energy won a Bihar link for a 2,400 megawatt power plant
Adani Energy Solutions Ltd secured a tariff-based transmission project on 19 November 2026 to evacuate power from the 2,400 MW Pirpainti thermal plant in Bihar, adding 881 circuit kilometres and about ₹500 crore of annual regulated revenue when the lines go live by late 2028.
Consumer durables / travel goods
VIP Industries is pushing premium luggage after two growth quarters
Managing director Atul Jain said on 19 November 2026 that VIP Industries grew consolidated revenue 15% in the September quarter, narrowed losses, and leaned on premium SKUs, roughly 65 new ranges, and wider retail reach while passing three price hikes totalling 7–8% in six months.
For informational purposes only. Not investment advice. Verify with filings and a licensed adviser.